EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.
Also called NCT01435031
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT01435031
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01435031. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-02 (actual). Results posted on 2014-11-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
- Acronym
- EXPERT CTO
- Condition
- Chronic Total Occlusion (CTO)
- Intervention (Device)
- CTO Treatment Device
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01435031- Content hash
9709f8a08e9daf02146ac4035f43b19fbc1c1d0f024f1c40e85349e3819c9185